BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35264244)

  • 21. Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1α expression.
    Lindgren A; Anttila M; Rautiainen S; Arponen O; Hämäläinen K; Könönen M; Vanninen R; Sallinen H
    PLoS One; 2019; 14(8):e0221340. PubMed ID: 31437208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
    Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
    Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perfusion-sensitive parameters of intravoxel incoherent motion MRI in rectal cancer: evaluation of reproducibility and correlation with dynamic contrast-enhanced MRI.
    Yang X; Xiao X; Lu B; Chen Y; Wen Z; Yu S
    Acta Radiol; 2019 May; 60(5):569-577. PubMed ID: 30114928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of arterial input function selection on kinetic parameters in brain dynamic contrast-enhanced MRI.
    Keil VC; Mädler B; Gieseke J; Fimmers R; Hattingen E; Schild HH; Hadizadeh DR
    Magn Reson Imaging; 2017 Jul; 40():83-90. PubMed ID: 28438713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravoxel Incoherent Motion Combined With Dynamic Contrast-Enhanced Perfusion MRI of Early Cervical Carcinoma: Correlations Between Multimodal Parameters and HIF-1α Expression.
    Li X; Wu S; Li D; Yu T; Zhu H; Song Y; Meng L; Fan H; Xie L
    J Magn Reson Imaging; 2019 Sep; 50(3):918-929. PubMed ID: 30648775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging.
    Ahn SS; Shin NY; Chang JH; Kim SH; Kim EH; Kim DW; Lee SK
    J Neurosurg; 2014 Aug; 121(2):367-73. PubMed ID: 24949678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histogram Analysis Comparison of Monoexponential, Advanced Diffusion-Weighted Imaging, and Dynamic Contrast-Enhanced MRI for Differentiating Borderline From Malignant Epithelial Ovarian Tumors.
    He M; Song Y; Li H; Lu J; Li Y; Duan S; Qiang J
    J Magn Reson Imaging; 2020 Jul; 52(1):257-268. PubMed ID: 31922327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
    Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
    World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of dynamic contrast-enhanced magnetic resonance imaging for determining the plasma Epstein-Barr virus status and staging of nasopharyngeal carcinoma.
    Sriyook A; Lertbutsayanukul C; Jittapiromsak N
    Clin Imaging; 2021 Apr; 72():1-7. PubMed ID: 33190027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation Between Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameters in Rectal Cancer.
    Sun H; Xu Y; Xu Q; Duan J; Zhang H; Liu T; Li L; Chan Q; Xie S; Wang W
    Acad Radiol; 2019 Jul; 26(7):e134-e140. PubMed ID: 30268719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of tracer kinetic parameters in cervical cancer using dynamic contrast-enhanced MRI as biomarkers in terms of biological relevance, diagnostic performance and inter-center variability.
    Wang X; Li S; Lin X; Lu Y; Mao C; Ye Z; Li X; Koh TS; Liu J; Liu J; Ma X; Cheng J; Ning G; Yan Z; Hou Z
    Front Oncol; 2022; 12():958219. PubMed ID: 36324571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
    Li X; Abramson RG; Arlinghaus LR; Kang H; Chakravarthy AB; Abramson VG; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Yankeelov TE
    Invest Radiol; 2015 Apr; 50(4):195-204. PubMed ID: 25360603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
    Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
    Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer.
    Ma XZ; Lv K; Sheng JL; Yu YX; Pang PP; Xu MS; Wang SW
    Oncol Lett; 2019 Mar; 17(3):3077-3084. PubMed ID: 30867737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative histogram parameters of dynamic contrast-enhanced MRI as a potential imaging biomarker for assessing the expression of Ki-67 in prostate cancer.
    Zhang Y; Li Z; Gao C; Shen J; Chen M; Liu Y; Cao Z; Pang P; Cui F; Xu M
    Cancer Med; 2021 Jul; 10(13):4240-4249. PubMed ID: 34117733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Application of dynamic-contrast enhanced magnetic resonance pharmacokinetic models in differential diagnosis of cellular uterine leiomyoma].
    Wang S; Zhao Z; Hu H; Yang J; Zhao L; Yang L; Wang C
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(5):498-504. PubMed ID: 29488716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative vascular heterogeneity and aggressiveness assessment of pituitary macroadenoma based on dynamic contrast-enhanced MRI texture analysis.
    Liu YQ; Gao BB; Dong B; Padikkalakandy Cheriyath SS; Song QW; Xu B; Wei Q; Xie LZ; Guo Y; Miao YW
    Eur J Radiol; 2020 Aug; 129():109125. PubMed ID: 32593076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the Depth of Myometrial Invasion of Endometrial Carcinoma: Comparison of Orthogonal Pelvis-axial Contrast-enhanced and Uterus-axial Dynamic Contrast-enhanced MRI Protocols.
    Ma X; Qiang J; Zhang G; Cai S; Ma F; Liu J
    Acad Radiol; 2022 Aug; 29(8):e119-e127. PubMed ID: 34645571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic Contrast-Enhanced MRI Kinetic Parameters as Prognostic Biomarkers for Prediction of Survival of Patient with Advanced Hepatocellular Carcinoma: A Pilot Comparative Study.
    Lee SH; Hayano K; Zhu AX; Sahani DV; Yoshida H
    Acad Radiol; 2015 Nov; 22(11):1344-60. PubMed ID: 26211553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.